Arrowhead Research reported 39.19 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
Incyte 54.54 40.08 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 68.1 16.21 Sep/2026
Merck 34.36 2.11 Sep/2026
Moderna 27.22 14.51 Jun/2023
Novartis 19.17 3.24 Sep/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
TG Therapeutics 75.56 55.92 Sep/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026
Xencor 29.92 3.22 Sep/2022